Jon Waldron

465 total citations
11 papers, 315 citations indexed

About

Jon Waldron is a scholar working on Clinical Psychology, Pharmacology and Toxicology. According to data from OpenAlex, Jon Waldron has authored 11 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 4 papers in Pharmacology and 3 papers in Toxicology. Recurrent topics in Jon Waldron's work include Cannabis and Cannabinoid Research (3 papers), Forensic Toxicology and Drug Analysis (3 papers) and Psychedelics and Drug Studies (3 papers). Jon Waldron is often cited by papers focused on Cannabis and Cannabinoid Research (3 papers), Forensic Toxicology and Drug Analysis (3 papers) and Psychedelics and Drug Studies (3 papers). Jon Waldron collaborates with scholars based in United Kingdom, Netherlands and Sweden. Jon Waldron's co-authors include Adam Winstock, Madonna Devaney, Jason Ferris, Stephen J. Kaar, J. Michael Ramsey, Rohan Borschmann, Michael T. Lynskey, Valerie H. Curran, Jacqueline Michel and Dagmar Schmidt Etkin and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Drug and Alcohol Dependence and Journal of Psychopharmacology.

In The Last Decade

Jon Waldron

10 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Waldron United Kingdom 6 98 91 50 47 44 11 315
Ton Nabben Netherlands 9 42 0.4× 84 0.9× 45 0.9× 70 1.5× 57 1.3× 24 358
Sylvie Deheul France 15 73 0.7× 119 1.3× 79 1.6× 185 3.9× 24 0.5× 54 506
Michael A. Ueberall Germany 12 134 1.4× 22 0.2× 32 0.6× 72 1.5× 9 0.2× 28 588
Ainārs Stepens Latvia 7 40 0.4× 47 0.5× 40 0.8× 58 1.2× 3 0.1× 28 293
DE Moulin Canada 6 147 1.5× 11 0.1× 11 0.2× 127 2.7× 8 0.2× 10 419
Brian P. Skop United States 4 106 1.1× 14 0.2× 18 0.4× 18 0.4× 5 0.1× 6 306
Tatiana M. Doberczak United States 7 58 0.6× 21 0.2× 16 0.3× 13 0.3× 5 0.1× 12 562
Alison Welch United States 6 75 0.8× 4 0.0× 14 0.3× 78 1.7× 86 2.0× 7 311
Gopal Kodumudi United States 12 103 1.1× 7 0.1× 20 0.4× 35 0.7× 4 0.1× 23 564
Nikkie Aarts Netherlands 15 103 1.1× 7 0.1× 47 0.9× 23 0.5× 5 0.1× 24 459

Countries citing papers authored by Jon Waldron

Since Specialization
Citations

This map shows the geographic impact of Jon Waldron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Waldron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Waldron more than expected).

Fields of papers citing papers by Jon Waldron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Waldron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Waldron. The network helps show where Jon Waldron may publish in the future.

Co-authorship network of co-authors of Jon Waldron

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Waldron. A scholar is included among the top collaborators of Jon Waldron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Waldron. Jon Waldron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Blankers, Matthijs, Desirée Spronk, Wouter den Hollander, et al.. (2025). Three-day blues after ecstasy/MDMA use: Evidence from a longitudinal and daily analysis in the European nightlife scene. Drug and Alcohol Dependence. 276. 112881–112881.
2.
Dyck, Edith Van, Koen Ponnet, Jon Waldron, et al.. (2023). Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey Study. International Journal of Environmental Research and Public Health. 20(3). 1821–1821. 11 indexed citations
3.
Blankers, Matthijs, Marloes Kleinjan, Jon Waldron, et al.. (2023). Polydrug Use Typologies of Regular Ecstasy Users Visiting Electronic Dance Music Events: A Latent Class Analysis. European Addiction Research. 30(1). 52–64. 1 indexed citations
4.
Waldron, Jon, Meryem Grabski, Tom P. Freeman, Margriet van Laar, & Valerie H. Curran. (2023). Impact of the introduction of medical cannabis in the UK on risk perception and recreational use of cannabis: A longitudinal and cross-sectional analysis. 9. 2 indexed citations
5.
Grabski, Meryem, Jon Waldron, Tom P. Freeman, Margriet van Laar, & Valerie H. Curran. (2022). Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees. International Journal of Drug Policy. 102. 103612–103612. 5 indexed citations
6.
Feltmann, Kristin, Tobias H. Elgán, Anna K. Strandberg, et al.. (2021). Illicit Drug Use and Associated Problems in the Nightlife Scene: A Potential Setting for Prevention. International Journal of Environmental Research and Public Health. 18(9). 4789–4789. 17 indexed citations
7.
Grabski, Meryem, Jon Waldron, Tom P. Freeman, et al.. (2021). Drug Use Changes at the Individual Level: Results from a Longitudinal, Multisite Survey in Young Europeans Frequenting the Nightlife Scene. European Addiction Research. 28(2). 155–160. 4 indexed citations
8.
Waldron, Jon, et al.. (2018). Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability. Frontiers in Psychiatry. 9. 97–97. 4 indexed citations
9.
Kaar, Stephen J., Jason Ferris, Jon Waldron, et al.. (2016). Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. Journal of Psychopharmacology. 30(4). 395–401. 151 indexed citations
10.
Winstock, Adam, Michael T. Lynskey, Rohan Borschmann, & Jon Waldron. (2015). Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of Psychopharmacology. 29(6). 698–703. 90 indexed citations
11.
Michel, Jacqueline, et al.. (2005). AN ISSUE PAPER PREPARED FOR THE 2005 INTERNATIONAL OIL SPILL CONFERENCE: POTENTIALLY POLLUTING WRECKS IN MARINE WATERS. International Oil Spill Conference Proceedings. 2005(1). 1–40. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ton Nabben Breakdown of academic impact, for papers by Sylvie Deheul Breakdown of academic impact, for papers by Michael A. Ueberall Breakdown of academic impact, for papers by Ainārs Stepens Breakdown of academic impact, for papers by DE Moulin Breakdown of academic impact, for papers by Brian P. Skop Breakdown of academic impact, for papers by Tatiana M. Doberczak Breakdown of academic impact, for papers by Alison Welch Breakdown of academic impact, for papers by Gopal Kodumudi Breakdown of academic impact, for papers by Nikkie Aarts
Rankless by CCL
2026